Unaudited Financial Results for Q1 FY27

The Board approved the unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27). The results were reviewed by the Audit Committee and accompanied by an unmodified limited review report from statutory auditors N.M. Raiji & Co.

Key Financial Figures (Standalone, Rs. in Crores):

  • Revenue from Operations: ₹528.01 (vs. ₹405.53 in Q1 FY26, +30.2% YoY)
  • Other Income: ₹9.30
  • Total Revenue: ₹537.31
  • Total Expenses: ₹412.64
  • Profit Before Tax: ₹124.67 (vs. ₹66.34 in Q1 FY26, +87.9% YoY)
  • Tax Expense: ₹30.04 (Current Tax: ₹28.60, Deferred Tax: ₹1.44)
  • Profit After Tax: ₹94.63 (vs. ₹49.44 in Q1 FY26, +91.4% YoY)
  • Other Comprehensive Income: -₹0.19
  • Total Comprehensive Income: ₹94.44
  • Paid-up Share Capital: ₹10.23 Crores
  • Face Value per Share: ₹2.00
  • Basic EPS: ₹18.51 (not annualized)
  • Diluted EPS: ₹18.49 (not annualized)

Comparative Figures:

  • Previous Quarter (Q4 FY26): Revenue ₹386.91 Cr, PAT ₹45.37 Cr
  • Previous Year (Q1 FY26): Revenue ₹405.53 Cr, PAT ₹49.44 Cr
  • Full Year FY26: Revenue ₹1,535.85 Cr, PAT ₹180.00 Cr

Re-designation of Directors

Based on recommendations from the Nomination and Remuneration Committee and Audit Committee, the Board approved the following re-designations, subject to shareholder approval via Postal Ballot:

1. Mr. Yogesh M. Kothari (DIN: 00010015): Re-designated from Chairman and Managing Director to Executive Chairman (Whole-time Director, Executive Director) effective October 1, 2026, until completion of his existing term on March 31, 2030. Terms and conditions of appointment and remuneration remain unchanged from those approved by shareholders on September 14, 2024.

2. Mr. Kirat M. Patel (DIN: 00019239): Re-designated from Executive Director to Joint Managing Director effective October 1, 2026, until completion of his existing term on December 31, 2029. Terms and conditions remain unchanged from September 14, 2024 approval.

3. Mr. Suneet Y. Kothari (DIN: 00021421): Re-designated from Executive Director to Joint Managing Director effective October 1, 2026, until completion of his existing term on December 31, 2029. Terms and conditions remain unchanged from September 14, 2024 approval.

4. Mr. Rakesh Goyal (DIN: 07977008): Re-designated and appointed from Whole-time Director - Operations to Executive Director - Operations for a five-year term from April 1, 2027, to March 31, 2032, on revised terms and conditions of remuneration.

Director Backgrounds:

  • Yogesh M. Kothari (77): Chemical Engineer with Master's degrees from University of Massachusetts, promoter with 47+ years in chemical industry
  • Kirat M. Patel (73): B.Tech from IIT Mumbai, MMS (Finance) from Jamnalal Bajaj, with company since inception
  • Suneet Y. Kothari (50): Chemical Engineer from Cornell University, MBA from INSEAD, with company since 2001
  • Rakesh Goyal (57): B.Tech (Chemical) from IIT Kanpur, Diploma in Business Management from ICFAI Hyderabad, 32 years experience in manufacturing

Disclosure Note: Mr. Rakesh Goyal is involved in pending legal cases filed by National Peroxide Limited alleging financial irregularities, with trials ongoing before the Chief Metropolitan Magistrate Court and Bombay High Court.

Relationships: Mr. Yogesh M. Kothari is the father of Mr. Suneet Y. Kothari. Mr. Kirat M. Patel and Mr. Rakesh Goyal are not related to any other directors.

All directors are not debarred from holding office by any regulatory order.

Payment of Commission to Non-Executive Directors

Based on the recommendation of the Nomination and Remuneration Committee, the Board approved payment of commission to Non-Executive Directors at a rate not exceeding 1% of the company's net profits for a period of 5 years starting from the financial year commencing April 1, 2027 (FY28 to FY32). This approval is subject to shareholder approval via Postal Ballot.

Trading Window Update

Following the announcement of unaudited financial results, the Trading Window for Designated Persons, their Immediate Relatives, and Connected Persons will reopen from August 7, 2026.

Meeting Details

The Board meeting commenced at 12:45 PM and concluded at 2:10 PM on August 4, 2026.